🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested
This phase II/III trial tests whether it is possible to decrease the chance...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-10-22
Trial ID
NCT03984448
This phase Ib trial tests the safety, side effects, and best dose of iberdo...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2024-12-06
Trial ID
NCT06465316
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-25
Trial ID
NCT05554328
This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-01-30
Trial ID
NCT03878095
This phase I/II trial studies the side effects and best dose of iberdomide ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-28
Trial ID
NCT07437963
This phase I/II trial evaluates the best dose, side effects and possible be...
Status
Suspended
Location
Children's Hospital of Alabama
Start Date
2022-01-28
Trial ID
NCT04870944
This phase II trial studies how well nivolumab works in eliminating any rem...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-07-02
Trial ID
NCT02275533
Treatments Being Tested